NCT01634867

Brief Summary

This study will evaluate using intraosseous vascular access and intravenous vascular access to give pediatric patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2012

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 6, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

April 2, 2026

Status Verified

December 1, 2014

Enrollment Period

1.9 years

First QC Date

July 2, 2012

Last Update Submit

March 28, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Time from determination of need for vascular access for rapid sequence intubation to administration of first does of paralytic agent.

    Time from determination of need for vascular access for rapid sequence intubation to administration of first does of paralytic agent.

    during rapid sequence intubation procedure, average expected time frame 30 minutes

  • Time from vascular access to intubation first attempt, as indicated by the first attempt to visualize the larynx with the laryngoscope.

    Time from vascular access to intubation first attempt, as indicated by the first attempt to visualize the larynx with the laryngoscope.

    during rapid sequence intubation procedure, average expected time frame 30 minutes

  • time from vascular access to successful intubation

    time from vascular access to successful intubation

    during rapid sequence intubation procedure, average expected time frame 30 minutes

  • number of attempts necessary for successful intubation

    number of attempts necessary for successful intubation

    during rapid sequence intubation procedure, average expected time frame 30 minutes

Secondary Outcomes (5)

  • Intubation difficulty

    during rapid sequence intubation procedure, average time frame 30 minutes

  • operator satisfaction with intubating conditions

    during rapid sequence intubation procedure, average time frame 30 minutes

  • failure rate of endotracheal intubation

    during rapid sequence intubation procedure, average time frame 30 minutes

  • Time from presentation of patient to vascular access established

    during rapid sequence intubation procedure, average time frame 30 minutes

  • Determine the incidence of short term catheter related complications for each technique

    during emergency department stay, average time frame 24 hours

Study Arms (2)

Intraosseous (IO) drug delivery

patients in whom intraosseous (IO) vascular access has been established for rapid sequence intubation drug delivery.

Peripheral intravenous (IV) drug delivery

patients in whom peripheral intravenous (IV) vascular access has been established for rapid sequence intubation drug delivery.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients in the emergency department with airway difficulties requiring rapid sequence intubation.

You may qualify if:

  • subjects requiring rapid sequence intubation for whom rocuronium is chosen as the paralytic agent.
  • the operator chooses to place a peripheral intravenous or powered intraosseous catheter to permit rapid sequence intubation.

You may not qualify if:

  • subjects in whom vascular access for rapid sequence intubation drug administration was established prior to arrival to the emergency department.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Omaha Children's Hospital and Medical Center

Omaha, Nebraska, 68198, United States

Location

Related Publications (10)

  • Reades R, Studnek JR, Vandeventer S, Garrett J. Intraosseous versus intravenous vascular access during out-of-hospital cardiac arrest: a randomized controlled trial. Ann Emerg Med. 2011 Dec;58(6):509-16. doi: 10.1016/j.annemergmed.2011.07.020.

    PMID: 21856044BACKGROUND
  • Adnet F, Borron SW, Racine SX, Clemessy JL, Fournier JL, Plaisance P, Lapandry C. The intubation difficulty scale (IDS): proposal and evaluation of a new score characterizing the complexity of endotracheal intubation. Anesthesiology. 1997 Dec;87(6):1290-7. doi: 10.1097/00000542-199712000-00005.

    PMID: 9416711BACKGROUND
  • Leidel BA, Kirchhoff C, Bogner V, Braunstein V, Biberthaler P, Kanz KG. Comparison of intraosseous versus central venous vascular access in adults under resuscitation in the emergency department with inaccessible peripheral veins. Resuscitation. 2012 Jan;83(1):40-5. doi: 10.1016/j.resuscitation.2011.08.017. Epub 2011 Sep 3.

    PMID: 21893125BACKGROUND
  • Deakin CD, Nolan JP, Soar J, Sunde K, Koster RW, Smith GB, Perkins GD. European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support. Resuscitation. 2010 Oct;81(10):1305-52. doi: 10.1016/j.resuscitation.2010.08.017. No abstract available.

    PMID: 20956049BACKGROUND
  • Kleinman ME, de Caen AR, Chameides L, Atkins DL, Berg RA, Berg MD, Bhanji F, Biarent D, Bingham R, Coovadia AH, Hazinski MF, Hickey RW, Nadkarni VM, Reis AG, Rodriguez-Nunez A, Tibballs J, Zaritsky AL, Zideman D; Pediatric Basic and Advanced Life Support Chapter Collaborators. Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2010 Oct 19;122(16 Suppl 2):S466-515. doi: 10.1161/CIRCULATIONAHA.110.971093.

    PMID: 20956258BACKGROUND
  • Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009 Feb;37(2):666-88. doi: 10.1097/CCM.0b013e31819323c6.

    PMID: 19325359BACKGROUND
  • Von Hoff DD, Kuhn JG, Burris HA 3rd, Miller LJ. Does intraosseous equal intravenous? A pharmacokinetic study. Am J Emerg Med. 2008 Jan;26(1):31-8. doi: 10.1016/j.ajem.2007.03.024.

    PMID: 18082778BACKGROUND
  • Orlowski JP, Porembka DT, Gallagher JM, Lockrem JD, VanLente F. Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs. Am J Dis Child. 1990 Jan;144(1):112-7. doi: 10.1001/archpedi.1990.02150250124049.

    PMID: 1688484BACKGROUND
  • Laurin EG, Sakles JC, Panacek EA, Rantapaa AA, Redd J. A comparison of succinylcholine and rocuronium for rapid-sequence intubation of emergency department patients. Acad Emerg Med. 2000 Dec;7(12):1362-9. doi: 10.1111/j.1553-2712.2000.tb00493.x.

    PMID: 11099426BACKGROUND
  • Perry JJ, Lee JS, Sillberg VA, Wells GA. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD002788. doi: 10.1002/14651858.CD002788.pub2.

    PMID: 18425883BACKGROUND

Study Officials

  • Edward Truemper, MD

    University of Nebraska

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2012

First Posted

July 6, 2012

Study Start

September 1, 2012

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

April 2, 2026

Record last verified: 2014-12

Locations